Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis | 6 | 2023 | 140 | 1.430 |
Why?
|
| Parathyroid Hormone | 11 | 2023 | 43 | 1.280 |
Why?
|
| Fibroblast Growth Factors | 13 | 2022 | 66 | 1.070 |
Why?
|
| Calcium | 11 | 2023 | 557 | 0.960 |
Why?
|
| Bone and Bones | 12 | 2024 | 137 | 0.920 |
Why?
|
| Bone Diseases | 1 | 2024 | 21 | 0.890 |
Why?
|
| Osteocytes | 2 | 2020 | 12 | 0.830 |
Why?
|
| Glucuronidase | 8 | 2018 | 23 | 0.800 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 312 | 0.700 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 14 | 0.690 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2020 | 26 | 0.680 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 2 | 2017 | 11 | 0.680 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 61 | 0.670 |
Why?
|
| Phosphates | 12 | 2017 | 90 | 0.620 |
Why?
|
| Bone Resorption | 3 | 2023 | 41 | 0.600 |
Why?
|
| Genetic Vectors | 1 | 2024 | 808 | 0.580 |
Why?
|
| Dependovirus | 1 | 2024 | 652 | 0.570 |
Why?
|
| Claudins | 1 | 2017 | 5 | 0.560 |
Why?
|
| Genetic Therapy | 1 | 2024 | 733 | 0.560 |
Why?
|
| Tight Junctions | 1 | 2017 | 20 | 0.550 |
Why?
|
| Extremities | 1 | 2017 | 44 | 0.540 |
Why?
|
| Signal Transduction | 6 | 2020 | 2901 | 0.530 |
Why?
|
| Gene Expression Regulation | 10 | 2017 | 1553 | 0.530 |
Why?
|
| Duodenum | 2 | 2006 | 42 | 0.510 |
Why?
|
| Animals | 34 | 2024 | 19664 | 0.470 |
Why?
|
| Mice | 23 | 2024 | 10301 | 0.440 |
Why?
|
| Kidney | 9 | 2023 | 414 | 0.400 |
Why?
|
| Osteoclasts | 4 | 2023 | 47 | 0.370 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 3 | 2023 | 5 | 0.370 |
Why?
|
| Mice, Knockout | 8 | 2020 | 1997 | 0.330 |
Why?
|
| Lipid Metabolism | 2 | 2007 | 203 | 0.290 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 114 | 0.280 |
Why?
|
| Osteoblasts | 7 | 2023 | 195 | 0.270 |
Why?
|
| Calcification, Physiologic | 4 | 2015 | 20 | 0.260 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2006 | 2 | 0.260 |
Why?
|
| Immobilization | 1 | 2006 | 12 | 0.250 |
Why?
|
| Homeostasis | 6 | 2023 | 346 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3236 | 0.250 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 29 | 0.250 |
Why?
|
| Vitamin D | 6 | 2023 | 132 | 0.240 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 720 | 0.240 |
Why?
|
| Gene Expression | 3 | 2007 | 810 | 0.240 |
Why?
|
| Bone Development | 2 | 2022 | 29 | 0.220 |
Why?
|
| Osteopontin | 2 | 2014 | 22 | 0.210 |
Why?
|
| Lead | 1 | 2022 | 41 | 0.200 |
Why?
|
| Stress, Psychological | 1 | 2006 | 442 | 0.190 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 303 | 0.190 |
Why?
|
| Cell Line | 3 | 2020 | 1984 | 0.190 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 8 | 0.190 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2023 | 4 | 0.180 |
Why?
|
| Calcitriol | 5 | 2017 | 24 | 0.180 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 3 | 2016 | 4 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 652 | 0.180 |
Why?
|
| Humans | 23 | 2024 | 59457 | 0.180 |
Why?
|
| Parathyroid Glands | 2 | 2018 | 8 | 0.180 |
Why?
|
| Rats | 7 | 2012 | 1911 | 0.180 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 322 | 0.160 |
Why?
|
| Hyperphosphatemia | 3 | 2016 | 3 | 0.160 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 295 | 0.160 |
Why?
|
| Glycoproteins | 2 | 2012 | 187 | 0.160 |
Why?
|
| Isomaltose | 2 | 2008 | 2 | 0.150 |
Why?
|
| Oleic Acid | 2 | 2008 | 21 | 0.150 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 1368 | 0.140 |
Why?
|
| RANK Ligand | 3 | 2023 | 22 | 0.140 |
Why?
|
| Phosphorylation | 1 | 2020 | 885 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 124 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 65 | 0.130 |
Why?
|
| Renal Elimination | 1 | 2016 | 3 | 0.130 |
Why?
|
| Kidney Tubules | 1 | 2016 | 18 | 0.130 |
Why?
|
| Aging | 2 | 2017 | 710 | 0.130 |
Why?
|
| Rats, Wistar | 2 | 2006 | 179 | 0.120 |
Why?
|
| Hypophosphatemia, Familial | 3 | 2011 | 5 | 0.120 |
Why?
|
| Cell Differentiation | 4 | 2023 | 1304 | 0.120 |
Why?
|
| Dental Implants | 1 | 2013 | 2 | 0.110 |
Why?
|
| Osseointegration | 1 | 2013 | 5 | 0.110 |
Why?
|
| Glycemic Index | 1 | 2013 | 22 | 0.110 |
Why?
|
| Glucose | 2 | 2007 | 445 | 0.110 |
Why?
|
| Leukocytes | 1 | 2013 | 97 | 0.100 |
Why?
|
| Titanium | 1 | 2013 | 56 | 0.100 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 29 | 0.100 |
Why?
|
| Diet | 2 | 2007 | 497 | 0.100 |
Why?
|
| Dietary Proteins | 2 | 2009 | 42 | 0.090 |
Why?
|
| Anabolic Agents | 1 | 2011 | 7 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2012 | 47 | 0.090 |
Why?
|
| Growth Plate | 1 | 2011 | 9 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2012 | 58 | 0.090 |
Why?
|
| Osteochondrodysplasias | 1 | 2011 | 11 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2017 | 307 | 0.090 |
Why?
|
| Calcinosis | 1 | 2012 | 79 | 0.090 |
Why?
|
| Aorta | 1 | 2012 | 108 | 0.090 |
Why?
|
| Obesity | 2 | 2009 | 1166 | 0.090 |
Why?
|
| Triiodothyronine | 1 | 2010 | 26 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2011 | 365 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2009 | 16 | 0.080 |
Why?
|
| Hypertriglyceridemia | 1 | 2009 | 8 | 0.080 |
Why?
|
| Quercetin | 1 | 2009 | 26 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 428 | 0.080 |
Why?
|
| Uterus | 1 | 2009 | 40 | 0.080 |
Why?
|
| Ovariectomy | 1 | 2009 | 96 | 0.080 |
Why?
|
| Calcium Channel Agonists | 1 | 2009 | 11 | 0.080 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2009 | 18 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 529 | 0.080 |
Why?
|
| Male | 11 | 2021 | 27784 | 0.080 |
Why?
|
| Inflammation | 3 | 2023 | 1099 | 0.070 |
Why?
|
| Bone Density | 3 | 2017 | 129 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 851 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2009 | 98 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2013 | 850 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2018 | 1469 | 0.070 |
Why?
|
| Caveolin 1 | 1 | 2007 | 7 | 0.070 |
Why?
|
| Phosphorus, Dietary | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cordyceps | 1 | 2007 | 1 | 0.070 |
Why?
|
| Diet Therapy | 1 | 2007 | 12 | 0.070 |
Why?
|
| Islets of Langerhans | 1 | 2008 | 271 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2017 | 75 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2011 | 2095 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 76 | 0.070 |
Why?
|
| Restraint, Physical | 1 | 2006 | 33 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 841 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2006 | 201 | 0.060 |
Why?
|
| Female | 9 | 2021 | 30766 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 206 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 169 | 0.060 |
Why?
|
| Symporters | 1 | 2004 | 13 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2005 | 279 | 0.050 |
Why?
|
| Antioxidants | 1 | 2005 | 241 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 24 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2013 | 461 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2011 | 1471 | 0.050 |
Why?
|
| Mitochondria | 1 | 2006 | 343 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2004 | 102 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 86 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2014 | 214 | 0.050 |
Why?
|
| Sp7 Transcription Factor | 1 | 2022 | 4 | 0.050 |
Why?
|
| Maxilla | 1 | 2022 | 3 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2051 | 0.050 |
Why?
|
| Random Allocation | 1 | 2021 | 193 | 0.040 |
Why?
|
| Base Sequence | 3 | 2008 | 1302 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2013 | 153 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2013 | 112 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 152 | 0.040 |
Why?
|
| Osteomalacia | 2 | 2012 | 5 | 0.040 |
Why?
|
| Sucrose | 2 | 2009 | 28 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2012 | 183 | 0.040 |
Why?
|
| Hyperparathyroidism | 1 | 2018 | 7 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2018 | 8 | 0.040 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2018 | 6 | 0.040 |
Why?
|
| Hypophosphatemia | 1 | 2018 | 6 | 0.040 |
Why?
|
| Rats, Zucker | 2 | 2008 | 7 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2010 | 526 | 0.040 |
Why?
|
| Hypocalcemia | 1 | 2018 | 16 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2018 | 85 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 115 | 0.040 |
Why?
|
| COS Cells | 2 | 2010 | 174 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 67 | 0.040 |
Why?
|
| Opossums | 2 | 2009 | 3 | 0.040 |
Why?
|
| Phenotype | 2 | 2011 | 1138 | 0.040 |
Why?
|
| DNA Primers | 2 | 2008 | 289 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 1151 | 0.030 |
Why?
|
| Body Weight | 2 | 2009 | 369 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2016 | 1 | 0.030 |
Why?
|
| Aging, Premature | 1 | 2016 | 2 | 0.030 |
Why?
|
| Calbindins | 1 | 2015 | 10 | 0.030 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2015 | 3 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 805 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 1 | 2013 | 23 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 1953 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2013 | 76 | 0.030 |
Why?
|
| Uremia | 1 | 2013 | 9 | 0.030 |
Why?
|
| Calcineurin | 1 | 2013 | 43 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 191 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 2011 | 7 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 298 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 165 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2011 | 39 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 90 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 399 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 341 | 0.020 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2010 | 26 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 64 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 43 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 3621 | 0.020 |
Why?
|
| Myocardium | 1 | 2012 | 264 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 293 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 106 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 328 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 673 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 619 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 188 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 95 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2009 | 27 | 0.020 |
Why?
|
| Fasting | 1 | 2009 | 48 | 0.020 |
Why?
|
| Flavonoids | 1 | 2009 | 73 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 314 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1206 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2008 | 19 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2008 | 58 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 356 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 153 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2009 | 137 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 574 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 584 | 0.020 |
Why?
|
| Sphingomyelins | 1 | 2007 | 3 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 32 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2007 | 21 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 254 | 0.020 |
Why?
|
| Receptors, Calcitonin | 1 | 2007 | 1 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2007 | 7 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 131 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 46 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2007 | 20 | 0.020 |
Why?
|
| Food, Formulated | 1 | 2007 | 10 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2007 | 108 | 0.020 |
Why?
|
| Cathepsins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Pancreas | 1 | 2007 | 146 | 0.020 |
Why?
|
| Tibia | 1 | 2007 | 71 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 59 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 9 | 0.020 |
Why?
|
| Adipocytes | 1 | 2008 | 255 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2007 | 132 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 234 | 0.020 |
Why?
|
| Triglycerides | 1 | 2007 | 231 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 33 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 24 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2005 | 66 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2005 | 80 | 0.020 |
Why?
|
| Cholesterol | 1 | 2007 | 253 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2006 | 355 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1555 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 81 | 0.020 |
Why?
|
| Cattle | 1 | 2005 | 304 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 191 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 226 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2005 | 98 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2005 | 146 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2007 | 283 | 0.010 |
Why?
|
| Monocytes | 1 | 2007 | 345 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 460 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 205 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 178 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type II | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2004 | 2 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 196 | 0.010 |
Why?
|
| Chromosomes, Human, X | 1 | 2004 | 35 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 590 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2004 | 53 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1033 | 0.010 |
Why?
|
| Liver | 1 | 2007 | 796 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 284 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 1119 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 1513 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 1015 | 0.010 |
Why?
|
| Adult | 2 | 2006 | 15697 | 0.010 |
Why?
|
| Quality of Life | 1 | 2004 | 1138 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 13427 | 0.000 |
Why?
|
| Middle Aged | 1 | 2004 | 16338 | 0.000 |
Why?
|